Why does another offer look so different?
You find a much lower price beside the word compounded. Is that just a different name for the same thing?
First find out what product is being offered. A price comparison makes little sense until the product is clear.
Compounded means made to order
A compounded medicine starts with a pharmacist or doctor preparing it for a patient, in place of a finished medicine from the drug maker.
Compounded medicines still lacked FDA approval when checked September 26, 2026. FDA is short for the Food and Drug Administration.
Before those preparations reach the market, the FDA does no review of their quality, benefit, or harm.
A compounded preparation may fill a gap in a patient’s care when approved products cannot, without becoming an approved brand itself.
The shortage route has ended
A national shortage once allowed wider copying of tirzepatide under the compounding rules.
The September 26, 2026 check found no tirzepatide entry on the FDA’s national shortage list.
After the shortage ended, the FDA gave medicine makers extra time before taking action over copies made under the shortage rules.
For ordinary compounding pharmacies, the FDA extended its original February 18, 2025 deadline until the court ruled on March 5, 2025.
For larger sites called outsourcing facilities, it ended on March 19, 2025.
Registered sites known as outsourcing facilities produce sterile medicines in batches.
A sterile preparation contains no living germs.
As of September 26, 2026, federal law still restricted routine copies of medicines already sold by a drug maker.
For an ordinary pharmacy, one exception concerns a change to the medicine for a particular patient. The prescriber must decide that the change makes a real difference for that patient compared with the drug already sold.
A lower price alone does not establish that difference.
Compounding can still be allowed for some patient needs. The old shortage alone is no longer a reason to make copies. Ask what change to the medicine is needed for your health and what rule allows it.
Generic and research labels mean different things
The word generic refers to a version of a brand-name medicine that has received approval.
No approved generic of tirzepatide was available as of September 26, 2026.
At that date, the FDA warned against tirzepatide offered for human use under research labels, because its quality was unknown and it could cause harm.
A research label is not a care route. Pause if an offer asks you to act as your own prescriber.
Read the distinction at its source
The FDA explains compounding
This explains what compounding can do and why a compounded product has not gone through the drug approval review.
The FDA’s shortage and copy-policy updates
Read the dated entries rather than treating an old shortage headline as permission that lasts forever.